Treatment.com AI Grants Stock Option and RSUs
From GlobeNewswire: 2025-06-20 17:26:00
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) has granted 799,920 restricted share units and 162,480 stock options to officers, directors, consultants, and employees. The options are exercisable for one common share at C$0.50 per share for three years, while the RSUs vest over one to five years. The company has engaged FN Media Group, LLC for a one-day news/media marketing campaign at a cost of USD$4,295. Treatment.com AI utilizes AI to improve healthcare through its Global Library of Medicine platform, providing support to healthcare professionals and disenfranchised communities. For more information, visit www.treatment.com.
Read more at GlobeNewswire: Treatment.com AI Grants Stock Option and RSUs